Cobenfy, the main asset acquired through Bristol Myers’ $14 billion purchase of Karuna, had $10 million in sales in the fourth quarter and is around 1,000 prescriptions weekly by late January.
Doctors treating Valdo Calocane, who was diagnosed with paranoid schizophrenia and murdered two university students and a school caretaker, refrained from giving him long lasting depot injections of ...
Prosecutors accepted a plea of manslaughter after experts agreed Valdo Calocane's schizophrenia meant he was not fully responsible for his actions - but this has now been contested.